3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Not yet recruiting
2
Unknown
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
35
Breast Neoplasms
19
Neoplasms
18
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Interventions
Oxaliplatin
80
S 1 (combination)
55
Capecitabine
44
apatinib
32
Docetaxel
32
Paclitaxel
31
Irinotecan
27
Fluorouracil
22
Drug Therapy
21
sintilimab
20
Cisplatin
20
Leucovorin
16
Hyperthermic Intraperitoneal Chemotherapy
13
XELOX
12
Surgical Procedures, Operative
12
camrelizumab
10
Trastuzumab
10
titanium silicide
9
pembrolizumab
9
Tegafur
9
Nivolumab
8
Neoadjuvant Therapy
8
Laparoscopy
8
Gastrectomy
8
Ramucirumab
7
Folfox protocol
7
Chemotherapy, Adjuvant
7
toripalimab
6
Gastroscopy
6
Epirubicin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Stomach Neoplasms
×
Exercise
×
Clear all
NCT06254300
2024-02-12
On4Cancer
University of Maia
Phase NA
Unknown
40 enrolled